{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:25:59Z","timestamp":1792279559587,"version":"4.4.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251213-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The prevalence of depression is higher in cancer survivors than in the general population. As the long-term cancer survivor population increases, it is increasingly important to understand risk factors for late-onset depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251213-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify risk factors associated with late-onset depression in long-term (5-year) survivors of breast, prostate, or colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251213-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study used 2022 linkage of Surveillance, Epidemiology, and End Results (SEER) and Medicare data to identify 5-year survivors of breast, prostate, or colorectal cancer 66 years or older who were enrolled in fee-for-service Medicare and had no previous depression diagnosis. Long-term survivors were diagnosed with cancer between January 1, 2007, and December 31, 2012, and followed up between January 1, 2008, and December 31, 2020. Data analysis was performed from August 2024 to July 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251213-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Sociodemographic and cancer-specific characteristics, treatment within 1 year after diagnosis, comorbidities within 1 year before cancer diagnosis, and previous diagnosis of anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251213-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was late-onset depression 5 to 10 years after cancer diagnosis, identified using a validated claims-based algorithm. Analyses were conducted separately for each survivor cohort. Fine-Gray subdistribution hazard regression, accounting for the competing risk of mortality, was used to identify factors associated with late-onset depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251213-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 53\u202f769 survivors were identified, including 13\u202f265 breast, 26\u202f979 prostate, and 13\u202f525 colorectal cancer survivors (mean [SD] age, 74.1 [5.8] years; 31 279 [61.9%] male; 2375 [4.4%] Asian or Pacific Islander, 2691 [5.0%] Hispanic, 3906 [7.3%] non-Hispanic Black, 43 986 [81.8%] non-Hispanic White, and 811 [1.5%] other or unknown) were identified. The 5-year risk of late-onset depression was highest in breast cancer survivors (13.3% [1768 of 13 265]), compared with prostate (8.7% [2360 of 26 979]) and colorectal (11.8% [1591 of 13 525]) cancer survivors. Older age was associated with greater hazard of depression among some categories (eg, prostate cancer survivors aged \u226590 years vs 71-74 years: HR, 1.57; 95% CI, 1.10-2.24) but not among others (eg, colorectal cancer survivors aged \u226590 years vs 71-74 years: HR, 1.02; 95% CI, 0.84-1.24). Variables that were consistently associated with greater hazard of depression included Medicare-Medicaid dual eligibility (eg, dual eligible breast cancer survivors vs non-dual eligible: HR, 1.38; 95% CI, 1.22-1.57), anxiety (eg, prostate cancer survivors: HR, 2.82; 95% CI, 2.47-3.22), and comorbidity burden (eg, breast cancer survivors: HR, 1.33; 95% CI, 1.12-1.57). In prostate cancer survivors, receipt of radiotherapy with or without androgen deprivation therapy was also associated with higher risk (HR, 1.22; 95% CI, 1.10-1.36). The risk of depression among survivors in the high-risk tertile was twice as high compared with the low-risk tertile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251213-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of long-term cancer survivors, Medicare and Medicaid dual eligibility, higher comorbidity burden, and preexisting anxiety were independently associated with greater risk of late-onset depression. These findings suggest that these risk factors may be used to proactively inform survivorship care during the transition from cancer surveillance to preventive care, which could reduce the risk of inconsistent follow-up care for survivors that may drive socioeconomic and racial and ethnic disparities in depression screening and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.44812","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:31:27Z","timestamp":1764174687000},"page":"e2544812","source":"Crossref","is-referenced-by-count":10,"title":["Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer"],"prefix":"10.1001","volume":"8","author":[{"given":"Melissa","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Westvold","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Hyslop","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Silber","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Forman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Yasin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendai","family":"Kwaramba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Leapman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"},{"name":"Department of Urology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cecchini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Leeds","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut"},{"name":"Department of Surgery, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Spees","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina"},{"name":"Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina"},{"name":"Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary P.","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Oeffinger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"},{"name":"Duke Cancer Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela A.","family":"Dinan","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"2","key":"zoi251213r2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2190\/PM.40.2.c","article-title":"It\u2019s not over when it\u2019s over: long-term symptoms in cancer survivors\u2013a systematic review.","volume":"40","author":"Harrington","year":"2010","journal-title":"Int J Psychiatry Med"},{"issue":"3","key":"zoi251213r3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/j.pain.0000000000003056","article-title":"Co-occurrence of chronic pain and anxiety\/depression symptoms in U.S. adults: prevalence, functional impacts, and opportunities.","volume":"165","author":"De La Rosa","year":"2024","journal-title":"Pain"},{"issue":"1","key":"zoi251213r4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12885-023-11214-5","article-title":"Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.","volume":"23","author":"Joshy","year":"2023","journal-title":"BMC Cancer"},{"issue":"7","key":"zoi251213r5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00520-024-08696-9","article-title":"Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care.","volume":"32","author":"Haywood","year":"2024","journal-title":"Support Care Cancer"},{"issue":"12","key":"zoi251213r6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1037\/hea0000374","article-title":"Fear of recurrence in long-term cancer survivors: do cancer type, sex, time since diagnosis, and social support matter?","volume":"35","author":"Koch-Gallenkamp","year":"2016","journal-title":"Health Psychol"},{"issue":"2","key":"zoi251213r7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-based assessment of cancer survivors\u2019 financial burden and quality of life: a prospective cohort study.","volume":"11","author":"Zafar","year":"2015","journal-title":"J Oncol Pract"},{"issue":"9","key":"zoi251213r8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1634\/theoncologist.2015-0026","article-title":"Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients.","volume":"20","author":"Delgado-Guay","year":"2015","journal-title":"Oncologist"},{"issue":"18","key":"zoi251213r9","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.23.00293","article-title":"Management of anxiety and depression in adult survivors of cancer: ASCO guideline update.","volume":"41","author":"Andersen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"15","key":"zoi251213r10","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1200\/JCO.2013.52.4611","article-title":"Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.","volume":"32","author":"Andersen","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi251213r11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jnci\/djy232","article-title":"Personalized risk-stratified cancer follow-up care: its potential for healthier survivors, happier clinicians, and lower costs.","volume":"111","author":"Mayer","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"55","key":"zoi251213r13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jncimonographs\/lgz029","article-title":"Updated overview of the SEER-Medicare data: enhanced content and applications.","volume":"2020","author":"Enewold","year":"2020","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"10","key":"zoi251213r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"1","key":"zoi251213r16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1062860609346347","article-title":"Using administrative data to identify mental illness: what approach is best?","volume":"25","author":"Frayne","year":"2010","journal-title":"Am J Med Qual"},{"issue":"2","key":"zoi251213r17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53668","article-title":"Association of long-term exposure to air pollution with late-life depression in older adults in the US.","volume":"6","author":"Qiu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi251213r18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jclinepi.2014.09.010","article-title":"A systematic review identifies valid comorbidity indices derived from administrative health data.","volume":"68","author":"Yurkovich","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"446","key":"zoi251213r19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"10","key":"zoi251213r20","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions.","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"zoi251213r21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jclinepi.2016.03.031","article-title":"Regression coefficient-based scoring system should be used to assign weights to the risk index.","volume":"79","author":"Mehta","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi251213r22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"2","key":"zoi251213r23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11222-013-9424-2","article-title":"Group descent algorithms for nonconvex penalized linear and logistic regression models with grouped predictors.","volume":"25","author":"Breheny","year":"2015","journal-title":"Stat Comput"},{"issue":"11","key":"zoi251213r24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/JGP.0b013e3182011b66","article-title":"Twelve-month diagnosed prevalence of behavioral health disorders among elderly Medicare and Medicaid members.","volume":"19","author":"Lin","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"issue":"28","key":"zoi251213r25","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1200\/JCO.23.00857","article-title":"Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for Integrative Oncology-ASCO guideline.","volume":"41","author":"Carlson","year":"2023","journal-title":"J Clin Oncol"},{"issue":"9","key":"zoi251213r26","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/MLR.0000000000000572","article-title":"The effects of the transition from Medicaid to Medicare on health care use for adults with mental illness.","volume":"54","author":"Burns","year":"2016","journal-title":"Med Care"},{"issue":"9","key":"zoi251213r27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/MLR.0000000000001885","article-title":"Was unstable Medicaid coverage among older Medicare beneficiaries associated with worse clinical outcomes? evidence from the delivery of breast cancer care.","volume":"61","author":"Qin","year":"2023","journal-title":"Med Care"},{"key":"zoi251213r28","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-024-01668-2","article-title":"Experienced financial toxicity among long-term cancer survivors: results from a national cross-sectional survey.","author":"Klok","year":"2024","journal-title":"J Cancer Surviv"},{"issue":"1","key":"zoi251213r29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/OP.23.00833","article-title":"Associations of financial hardship and health status, social functioning, and mental health among cancer survivors in the United States: findings from a nationally representative study.","volume":"21","author":"Chen","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"12","key":"zoi251213r30","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1200\/OP.24.00025","article-title":"Exploring the relationship among financial hardship, anxiety, and depression in patients with cancer: a longitudinal study.","volume":"20","author":"Yanez","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"zoi251213r31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/archpsyc.64.3.305","article-title":"Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life.","volume":"64","author":"Williams","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"zoi251213r32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","article-title":"Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.","volume":"62","author":"Hasin","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"zoi251213r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1606","article-title":"Association of race and ethnicity with late-life depression severity, symptom burden, and care.","volume":"3","author":"Vyas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi251213r34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jpsychires.2010.04.031","article-title":"Limited English proficiency as a barrier to mental health service use: a study of Latino and Asian immigrants with psychiatric disorders.","volume":"45","author":"Kim","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"1","key":"zoi251213r35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijrobp.2023.11.049","article-title":"Depression and anxiety Among English- and Spanish-speaking patients with breast cancer receiving radiation therapy.","volume":"119","author":"Beiner","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"zoi251213r36","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1200\/JCO.2015.64.1969","article-title":"Association of androgen deprivation therapy with depression in localized prostate cancer.","volume":"34","author":"Dinh","year":"2016","journal-title":"J Clin Oncol"},{"issue":"11","key":"zoi251213r37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer.","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"key":"zoi251213r38","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300018","article-title":"Patient-reported outcomes 12 years after localized prostate cancer treatment.","author":"Donovan","year":"2023","journal-title":"NEJM Evid"},{"issue":"13","key":"zoi251213r39","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.3390\/cancers13133368","article-title":"Physical comorbidities and depression in recent and long-term adult cancer survivors: NHANES 2007-2018.","volume":"13","author":"Petrova","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"zoi251213r40","first-page":"41","article-title":"Cancer, comorbidities, and health-related quality of life of older adults.","volume":"29","author":"Smith","year":"2008","journal-title":"Health Care Financ Rev"},{"issue":"11","key":"zoi251213r41","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/jnci\/djae163","article-title":"Older adults with cancer and common comorbidities-challenges and opportunities in improving their cancer treatment outcomes.","volume":"116","author":"Chen","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi251213r42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s11136-020-02713-0","article-title":"Examination of individual and multiple comorbid conditions and health-related quality of life in older cancer survivors.","volume":"30","author":"Siembida","year":"2021","journal-title":"Qual Life Res"},{"key":"zoi251213r1","unstructured":"American Cancer Society. Cancer treatment & survivorship facts & figures 2022-2024. Accessed October 10, 2025. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-treatment-and-survivorship-facts-and-figures\/2022-cancer-treatment-and-survivorship-fandf-acs.pdf"},{"key":"zoi251213r12","unstructured":"Surveillance, Epidemiology, and End Results Program (SEER). SEER-Medicare: brief description of the seer-medicare database. Accessed October 10, 2025. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/overview\/"},{"key":"zoi251213r15","unstructured":"Centers for Medicare & Medicaid Services. CCW chronic conditions algorithms. Chronic Conditions Data Warehouse. Accessed November 20, 2024, https:\/\/www2.ccwdata.org\/documents\/10280\/19139421\/ccw-chronic-condition-algorithms.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2842068\/taylor_2025_oi_251213_1763583145.34335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:31:28Z","timestamp":1764174688000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2842068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.44812","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}